The EMA is already studying updated vaccines in order to better respond to the new sub-variables

by

Preventive medicine and public health
–

COVID-19

The first approvals of these “renewed vaccines” will arrive in September and are expected to have activity against the BA4 and BA5 variants, which are responsible for a slight recovery.

EMA warns that a rebound in SARS-CoV-2 infection has recently been observed in some European countries, in most cases due to the prevalence of BA4 and BA5 sub variants.

Leave a Comment